p300/MDM2 complexes participate in MDM2-mediated p53 degradation

被引:363
作者
Grossman, SR
Perez, M
Kung, AL
Joseph, M
Mansur, C
Xiao, ZX
Kumar, S
Howley, PM
Livingston, DM
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
[5] New England Med Ctr, Dept Dermatol, Boston, MA 02111 USA
[6] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[7] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
关键词
D O I
10.1016/S1097-2765(00)80140-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Control of p53 turnover is critical to p53 function. E1A binding to p300/CBP translates into enhanced p53 stability, implying that these coactivator proteins normally operate in p53 turnover control. In this regard, the p300 C/H1 region serves as a specific in vivo binding site for both p53 and MDM2, a naturally occurring p53 destabilizer. Moreover, most of the endogenous MDM2 is bound to p300, and genetic analysis implies that specific interactions of p53 and MDM2 with p300 C/H1 are important steps in the MDM2-directed turnover of p53. A specific role for p300 in endogenous p53 degradation is underscored by the p53-stabilizing effect of overproducing the p300 C/H1 domain. Taken together, the data indicate that specific interactions between p300/CBP C/H1, p53, and MDM2 are intimately involved in the MDM2-mediated control of p53 abundance.
引用
收藏
页码:405 / 415
页数:11
相关论文
共 56 条
  • [1] An essential role for p300/CBP in the cellular response to hypoxia
    Arany, Z
    Huang, LE
    Eckner, R
    Bhattacharya, S
    Jiang, C
    Goldberg, MA
    Bunn, HF
    Livingston, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) : 12969 - 12973
  • [2] Recruitment of p300/CBP in p53-dependent signal pathways
    Avantaggiati, ML
    Ogryzko, V
    Gardner, K
    Giordano, A
    Levine, AS
    Kelly, K
    [J]. CELL, 1997, 89 (07) : 1175 - 1184
  • [3] The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300
    Avantaggiati, ML
    Carbone, M
    Graessmann, A
    Nakatani, Y
    Howard, B
    Levine, AS
    [J]. EMBO JOURNAL, 1996, 15 (09) : 2236 - 2248
  • [4] Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells
    BeerRomero, P
    Glass, S
    Rolfe, M
    [J]. ONCOGENE, 1997, 14 (05) : 595 - 602
  • [5] Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo
    Bottger, A
    Bottger, V
    Sparks, A
    Liu, WL
    Howard, SF
    Lane, DP
    [J]. CURRENT BIOLOGY, 1997, 7 (11) : 860 - 869
  • [6] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA
    CHEN, C
    OKAYAMA, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) : 2745 - 2752
  • [7] REGULATION OF TRANSCRIPTION FUNCTIONS OF THE P53 TUMOR-SUPPRESSOR BY THE MDM-2 ONCOGENE
    CHEN, JD
    LIN, JY
    LEVINE, AJ
    [J]. MOLECULAR MEDICINE, 1995, 1 (02) : 142 - 152
  • [8] Chen JD, 1996, MOL CELL BIOL, V16, P2445
  • [9] p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis
    Chiou, SK
    White, E
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (05) : 3515 - 3525
  • [10] PROPERTIES OF P53 MUTATIONS DETECTED IN PRIMARY AND SECONDARY CERVICAL CANCERS SUGGEST MECHANISMS OF METASTASIS AND INVOLVEMENT OF ENVIRONMENTAL CARCINOGENS
    CROOK, T
    VOUSDEN, KH
    [J]. EMBO JOURNAL, 1992, 11 (11) : 3935 - 3940